AHN-GOOK PHARMACEUTICAL Co Ltd (001540) Stock Price & News

001540:KOSDAQ

AHN-GOOK PHARMACEUTICAL Co Ltd

₩9,530.00

+1.71%

(+160.00) 1D

Nov 13, 3:30:30 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 001540...

Open

₩9,370

High

₩9,620

Low

₩9,370

Mkt. cap

124.29B

Avg. vol.

29.37K

Volume

29.94K

Dividend

6.64%

Quarterly dividend

₩158

Ex-dividend date

Dec 27, 2023

P/E ratio

5.00

52-wk high

₩13,650

52-wk low

₩7,280

EPS

₩1,905

Shares outstanding

13.04M

No. of employees

394

Open

₩9,370

High

₩9,620

Low

₩9,370

Mkt. cap

124.29B

Avg. vol.

29.37K

Volume

29.94K

Dividend

6.64%

Quarterly dividend

₩158

Ex-dividend date

Dec 27, 2023

P/E ratio

5.00

52-wk high

₩13,650

52-wk low

₩7,280

EPS

₩1,905

Shares outstanding

13.04M

No. of employees

394

Related stocks

001060

JW Pharmaceutical Corp

₩23,650.00

+0.85%

000250

Sam Chun Dang Pharm Co Ltd

Samil Pharmaceutical Co Ltd

₩7,170.00

-3.24%

News stories

From web sources and news partners

Reuters

1 hour ago

Goldman Sachs sees S&P 500 rising to 8,700 next year despite slower earnings growth

Yahoo Finance

48 minutes ago

Stock market today: S&P 500, Nasdaq turn lower as wholesale inflation rises, Nvidia stock falls

CNBC

8 minutes ago

Nasdaq Composite slides as Nvidia shares tumble on Jensen Huang’s exit; oil prices jump

24/7 Wall St.

59 minutes ago

He Wants Anthropic in His S&P 500 401(k) as Soon as It Goes Public. One Index Rule Could Keep It Out for at Least 12 Months. Even Then, His Fund May Never Own It

About AHN-GOOK PHARMACEUTICAL Co Ltd

CEOWon Deok-kwon

Employees394

Founded1959

Headquarters-

SectorHealth Care

IndustryPharmaceutical industry

Websiteahn-gook.com

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	77.69B	76.61B	98.93B	91.85B
Cost of goods sold	26.19B	25.67B	32.81B	30.18B
Cost of revenue	26.19B	25.67B	32.81B	30.18B
Research and development expenses	4.68B	12.66B	3.81B	4.92B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	41.21B	43.59B	45.53B	47.31B
Operating expense	46.62B	56.84B	50.10B	53.03B
Total operating expenses	72.81B	82.52B	82.91B	83.21B
Operating income	4.88B	-5.91B	16.02B	8.64B
Other non operating income	5.71M	455.18M	-291.62M	1.46B
EBT including unusual items	4.43B	-5.52B	15.84B	11.43B
EBT excluding unusual items	4.30B	-6.27B	15.35B	8.51B
Income tax expense	1.07B	-2.91B	3.45B	2.86B
Effective tax rate	24.15%	52.69%	21.77%	25.01%
Other operating expenses	-	-	-	-
Net income	3.37B	-2.58B	12.37B	8.50B
Net profit margin	4.33%	-3.37%	12.51%	9.25%
Earnings per share	-	-	-	-
Interest and investment income	105.12M	122.27M	93.74M	150.99M
Interest expense	-661.98M	-647.18M	-634.58M	-666.04M
Net interest expenses	-556.87M	-524.92M	-540.83M	-515.05M
Depreciation and amortization charges	676.60M	458.82M	647.54M	665.23M
EBITDA	7.06B	-3.66B	18.38B	11.21B
Gain or loss from assets sale	1.00K	-25.97M	-	242.90M

Ask anything